back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-10 13:56 Tx date 2025-12-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,103.20
-2,010 vol $46.32 each |
6,000 | |
| Filed 2025-12-10 13:55 Tx date 2025-12-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-402,103.80
-8,820 vol $45.59 each |
8,010 | |
| Filed 2025-12-10 13:55 Tx date 2025-12-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-647,306.25
-14,375 vol $45.03 each |
16,830 | |
| Filed 2025-12-04 13:07 Tx date 2025-11-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,365.97
-97 vol $45.01 each |
31,205 | |
| Filed 2025-10-20 17:46 Tx date 2025-10-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Kelly, Thomas Patrick
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+30,000 vol |
30,000 | |
| Filed 2025-10-20 17:42 Tx date 2025-10-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Kelly, Thomas Patrick
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-20 17:41 Tx date 2025-10-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Kelly, Thomas Patrick
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
225,000 | |
| Filed 2025-10-20 17:35 Tx date 2025-10-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Kelly, Thomas Patrick
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 17:14 Tx date 2025-10-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,004,000
-25,000 vol $40.16 each |
31,302 | |
| Filed 2025-10-02 13:36 Tx date 2025-10-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-25,000 vol |
1,805,000 | |
| Filed 2025-10-02 13:25 Tx date 2025-10-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$192,250
+25,000 vol $7.69 each |
56,302 | |
| Filed 2025-06-25 12:57 Tx date 2025-06-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Cline, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+185,800 vol |
185,800 | |
| Filed 2025-06-25 12:51 Tx date 2025-06-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Cline, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 14:05 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2025-06-10 14:03 Tx date 2014-11-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 13:59 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2025-06-10 13:58 Tx date 2021-08-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 13:45 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2025-06-10 13:43 Tx date 2022-11-07 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 13:24 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+2,645 vol |
2,645 |